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Mood changes during the premenstrual phase
have been the focus of considerable research in
recent years. Although there has been signifi-
cant progress in the diagnosis and etiology of
major affective disorders, the relation between
these disorders and menstrual changes remains
controversial. There have been contradictory
reports and speculations on women's suscepti-
bility to psychiatric disorders during the pre-
menstrual phase. We describe three patients
with a history of mood swings associated with
menstruation in whom major affective disorders
developed, necessitating intensive psychiatric
treatment or admission to hospital. Among
women who manifest menstrual mood changes,
manic-depressive illness may develop only in a
subgroup with genetic predisposition. In such
cases the possibility of postpartum mania or
depression should be kept in mind in follow-up.
On a fait beaucoup de travaux depuis quelques
annees sur l'instabilite d'humeur de la femme a
la phase premenstruelle. Malgre d'importants
progres realisds dans le diagnostic et la cause
des principaux troubles affectifs, on ne s'accorde
pas sur leurs rapports avec les stades du cycle
menstruel. Il a ete publie notamment des obser-
vations et des speculations contradictoires sur la
predisposition des femmes aux troubles psychi-
ques a la phase prdmenstruelle. On decrit ici
trois malades dejk connues pour leur instabilite
d'humeur en rapport avec les rbgles, chez qui la
survenue d'importants troubles affectifs a exige
un traitement psychiatrique intense, voire
meme l'hospitalisation. Parmi les femmes qui
manifestent une telle instabilite, il se peut que
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la psychose maniaco-depressive ne survienne
que chez celles qui y sont predisposees gdneti-
quement. Chez celles-ci, il y a lieu de garder en
l'esprit l'eventualite d'une manie ou d'une
depression post-partum ulterieure.
TShere has been increasing interest in and
controversy over the possible relation be-
tween affective disorders and the menstrual
cycle in recent years. The concept of premenstrual
syndrome (PMS) arose from clinical observations
and anecdotal reports as well as much effort to
unravel the myth of psychopathologic symptoms
or syndromes that may be associated with the
menstrual cycle. PMS has not only baffled special-
ists in many fields but also influenced the judicial
system: in two cases a charge of murder was
changed to manslaughter on the basis of premen-
strual tension leading to temporary derangement
of judgement.'
There have been numerous reports of changes
in behavioural patterns in susceptible women dur-
ing the premenstrual phase: "periodic psychosis",2
"hyperestrogenic cyclic psychosis",3 "recurrent
menstrual psychosis"4 and "atypical endogenous
psychosis".5 The relation between psychiatric dis-
orders, such as major depression, and premenstru-
al mood disorder has been the subject of more
intensive research in recent years.
Conceptual definitions
There has been disagreement as to the meth-
ods for clinical assessment of menstrual changes
and the definition of premenstrual and paramen-
strual phases.6,7 "Premenstrual tension" was first
reported as a syndrome by Frank,8 in 1931, and
was described as a group of symptoms that would
appear 7 to 10 days before menstruation: signifi-
cant tension, irritability, strange behaviour, dys-
phoric mood and somatic complaints. All these
symptoms, according to Frank, would disappear
after the onset of the menstrual flow. Dalton9 and
Jacobs and Charles'0 defined the paramenstrual
phase as 4 days before and 4 days after menstrua-
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tion. PMS was defined in 1983 as "marked change
in intensity of symptoms measured (daily) from
cycle days 5 to 10, compared to the intensity
within the six-day interval prior to menses, for at
least two consecutive cycles'".'1
Dennerstein and Burrows'2 reviewed the find-
ings of 24 prospective studies of affective fluctua-
tions during the menstrual cycle. In most cases
they found that negative moods marked by irrita-
bility, restlessness, anxiety, tension, migraine,
sleep disturbance, impaired concentration and
heightened neurotic conflict occurred more often
during the premenstrual and menstrual phases
than at other times in the cycle. There were also a
few cases of positive moods, such as an increased
feeling of well-being, elation, pleasantness and
activation, during the follicular and midcycle
phases.
Halbreich and colleagues7 suggested that the
following criteria should be used to identify "pre-
menstrual changes": cyclic recurrence, mostly dur-
ing the premenstrual phase, a significant change in
the severity of symptoms as compared with the
usual state and return to the usual state shortly
after the beginning of menstrual flow.
Psychologic factors
It has been reported that whereas menstrual
problems appear to occur more frequently in youn-
ger than in older women, premenstrual symptoms
occur more often in older women.'3 This suggests a
relation between age and menstrual symptoms.
A study of personality traits of women suffer-
ing from premenstrual tension revealed that
women with traits of suspicion, guilt, apprehen-
sion, unpretentiousness and considerable self-con-
flict tended to suffer more from PMS than women
without these traits.14 They were more likely to be
separated or divorced, childless and dissatisfied
with work, not to be taking oral contraceptives
and to have sexual and emotional difficulties.
Current attitudes toward menstruation were close-
ly related to manifestations of certain menstrual
symptoms.
O'Neil and associates,"5 however, found no
significant or disruptive fluctuation in mood or
psychologic symptoms of distress during the
phases of the menstrual cycle in a large sample of
university women. They suggested that women
with distressing cyclic fluctuations are best studied
as a susceptible subgroup.
Factors responsible for a negative attitude to
menstruation include increased family tensions,
fearful attitudes toward menarche and the menses,
poor knowledge of and poor experience with
menses, poor acceptance and performance of the
feminine psychosocial role, and feelings of inabili-
ty to cope with daily life.'6 In general, women with
these traits show less ability to successfully cope
with intemal or external stress. However, whether
psychic changes lead to hormonal imbalance or
hormonal changes predispose to psychic changes is
still unclear.
Benedek and Rubinstein17,18 collected vaginal
smears daily from women undergoing psychoan-
alysis and analysed the smears in relation to
day-to-day variation in mood. They found that in
the estrogen phase there was activation of the
emotional state related to heterosexual feeling and
that ovulation was characterized by a sudden
decrease in active libido and by a surge of narcis-
sistic erotization of the body. After ovulation,
manifestations of receptive and retentive tenden-
cies dominated. Shainess,19 in a study of girls'
developing sexuality, found that for women in
whom PMS later developed, the mother-daughter
relationship had been poor at the time of menar-
che. She divided premenstrual symptoms into two
categories: one consisted of symptoms indicating a
longing for love and a state of helplessness, the
other, symptoms indicating a feeling of vulnerabili-
ty and an angry defence reaction in anticipation of
attack. Shainess considered these two categories of
symptoms as a reflection of the impoverishment of
ego and poor self-acceptance. She felt that the
onset of menstruation heralds the beginning of
womanhood as well as motherhood and generates
a certain amount of anxiety. This subjective feeling
occurs with each menstrual cycle and is therefore
implicated in PMS.
Subsequent studies showed that the impor-
tance in PMS of a woman's acceptance or rejection
of her feminine role is controversial. While some
researchers maintain that rejection of the tradition-
al feminine role is a contributing factor in premen-
strual distress, others disagree.20 The role of psy-
chosocial factors in PMS should be tempered with
the severity of the symptoms, and one should not
overlook the importance of biologic changes un-
derlying psychologic manifestations. In general,
psychosocial variables find their expression in the
milder form of PMS, but there are exceptions.
Other observations showed that there was an
increase in visits to outpatient clinics and hospital
admissions at the time of the menstrual period
among women with psychiatric symptoms.2' Ka-
shiwagi and coworkers22 reported that of 81
women 43 suffered from primary or secondary
depression, 14 suffered from nondepressive psy-
chiatric disorders and 24 had no psychiatric disor-
der. A total of 65% of the depressive group, 14%
of the nondepressive psychiatric group and 21% of
the third group were suffering from a premenstrual
affective syndrome.
DeJong and collaborators,23 in a prospective
study, explored the hypothesis that a special re-
lation exists between PMS and psychiatric disor-
ders, particularly affective illness. They reported
that of 57 women with PMS 30% had at some time
in their lives had a major affective disorder.
Ceppen and Kessel24 claimed that neuroticism
was related to premenstrual symptoms but not to
menstrual pain, whereas Stephenson and col-
leagues25 found a direct relation between menstrual
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pain and neuroticism. On the other hand, Ka-
shiwagi and coworkers22 found premenstrual affec-
tive syndrome only in neurotic patients who had
an element of depression. Wetzel and associates,26
in their study of 589 college students, showed that
premenstrual affective syndrome is a positive pre-
dictor for the development of major affective
disorders under stressful conditions. In their re-
view of the literature since the turn of the century
Wetzel and McClure27 found an exacerbation of
depressive symptoms and more suicide attempts
during the premenstrual phase.
There have been conflicting reports on the
relation between suicidal behaviour and the men-
strual cycle. While Dalton9 found a high correlation
between such behaviour and the menstrual cycle,
Buckle and coworkers28 found no relation. In
general, however, the risk of suicidal behaviour
seems to be increased during the menstrual phase.
Abramowitz and collaborators29 reported that
during the entire paramenstrual phase the day
before and the first day of menstrual flow were
associated with higher rates of admission among
depressed patients than among those with schizo-
phrenia. They suggested that estrogen levels drop
before menstruation and that this phenomenon is
associated with a rise in monoamine oxidase activi-
ty and depletion of catecholamines. However,
Dalton9 and Jacobs and Charles10 found no differ-
ence in admission rates during the paramenstrual
phase between depressed and schizophrenic pa-
tients.
Abplanalp and colleagues30'3' argued that un-
derstanding the psychologic aspects of menses was
hampered because study samples were not repre-
sentative of the adult female population. Further-
more, there was no clear-cut differentiation of
menstrual phases, as the cycle was divided by
calendar days, not hormonal days. In their study of
33 women they found no correlation between
menstrual cycle and daily-life activities. They
found that stressful life events had a greater effect
than menstrual cycle on mood and enjoyment of
daily life. Their study of hormonal profile also
failed to reveal any relation between psychologic
states and absolute levels of reproductive hor-
mones (estradiol and progesterone).
More recently O'Neil and associates,"5 in their
study of university women aged 18 to 30 years,
found no significant differences in levels of anxi-
ety, depression or psychologic distress between
various phases of the menstrual cycle (menses,
follicular, luteal and premenses).
Biologic factors
The increased importance of possible effects of
menstruation on mood cycles led specialists in
many fields to conduct an extensive search for the
cause. Endocrinologists tried to find an answer by
studying the various hormonal profiles during the
premenstrual phase.
Backstrom and associates32 showed that early
in the luteal phase, levels of estrogen and proges-
terone were lower in subjects with PMS than in
control subjects. However, 8 days before menstrua-
tion, as the control group showed a decline in
estrogen levels the PMS group exhibited a rise.
Progesterone levels remained low in the PMS
group throughout the luteal phase, thus altering
the estrogen:progesterone ratio. This finding, how-
ever, was not supported by other investigators.
Andersch and coworkers33 found no difference in
plasma levels of progesterone between control and
PMS groups. O'Brien and collaborators,34 on the
other hand, found higher plasma progesterone
levels in subjects with PMS immediately after
ovulation (10 days before menstruation) but no
other differences during the rest of the cycle. This
altered estrogen:progesterone ratio was thought to
be responsible for the premenstrual symptoms. It
has been reported that the brain has receptor sites
for both estrogen and progesterone, in the hypo-
thalamus and preoptic area." The progesterone
receptors, however, must first be induced by estro-
gen. Estrogen is thought to affect the number of
neurotransmitter receptors, particularly in the
brain. These changes coincide with a higher level
of follicle-stimulating hormone in women with
PMS.
Dennerstein and colleagues35 reported that
pregnanediol levels were significantly lower in
subjects with PMS than in control subjects during
both the follicular and luteal phases. In addition,
the first rise in pregnanediol levels occurred later
in the PMS group than in the control group. The
role of contraceptives in hormonal changes in the
premenstrual period is also controversial.20
Increased fluid retention and breast swelling
and tenderness led researchers to speculate that
prolactin plays a role, as it also potentiates the
function of aldosterone and antidiuretic hormone.
Halbreich and associates36 found a higher mean
prolactin level throughout the menstrual cycle in
28 women with PMS than in a group of control
subjects. Brush37 found that prolactin concentra-
tions tended to be higher in women with premen-
strual symptoms who had low progesterone levels.
However, Andersch and coworkers33 found lower
prolactin levels in subjects with PMS than in
control subjects during the follicular phase but not
the luteal phase.
Green and Miller38 found lower plasma con-
centrations of norepinephrine in rats during es-
trous and pregnancy than during diestrus. This
response may be seen to a greater degree in
premenstrual women. Janowsky and coworkers39
found a positive correlation between negative
mood, increased weight gain and increased urine
potassium:sodium ratio during the luteal phase of
the menstrual cycle, and a dramatic decrease in the
ratio after the onset of menstruation. They hypoth-
esized that complex interactions between the re-
nin-angiotensin-aldosterone system and ovarian
hormones indirectly influence the central neuro-
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transmitters (i.e., norepinephrine and catechola-
mine). However, Munday and collaborators40
found no elevations in the level of aldosterone and
ruled out this hormone as playing a role in
premenstrual tension. Some investigators also
failed to find a consistent relation between fluid
retention and menstrual tension.41
There are indications that opioid substances
such as endorphin play a role in the menstrual
cycle. Despite the lack of clear evidence, Reid and
Yen42 believe that a-melanocyte-stimulating hor-
mone, which has been shown to raise levels of
growth hormone43 and gonadotropins,44 plays a
role in the pathogenesis of PMS. They have
speculated that "this peptide is significantly influ-
enced by gonadal steroids and in concert with the
other intermediate lobe peptide ,3-endorphin, it
may modulate mood, behavior, and the integrated
function of both anterior and posterior pituitary".
Pyridoxine is a cofactor in the synthesis of the
immediate precursor of dopamine and also of
tryptophan. If tryptophan production is decreased,
the balance of the brain amines, particularly sero-
tonin, is upset, which leads to depression. Similar-
ly, pyridoxine deficiency may play a role in depres-
sion and in PMS, but this relation is controver-
sial.45'46
Paige,47 in her study of 102 women, reported
that menstrual distress was related to the intensity
of menstrual flow and consequently to sexual
abstinence during menstruation. Reduced menstru-
al flow as a result of contraceptives, on the other
hand, was associated with less anxiety and less
sexual abstinence. Paige replicated the findings of
Grant and Pryse-Davies,48 who had found that the
extent of depression, anger and irritability during
the menstrual period corresponded directly with
the magnitude of monoamine oxidase activity in
endometrial tissue. They concluded that endome-
trial monoamine oxidase activity is a reflection of
similar changes in the central nervous system and
hence is closely related to mood fluctuations.
Illustrative case reports
Case 1
A 25-year-old single woman had been treated
as an outpatient for mood swings since 1978.
When she became depressed she would experience
homosexual interest and fantasies, without any
homosexual relationship. She also showed mood-
congruent paranoid ideas when depressed. She
responded well to treatment with combination
perphenazine-amitriptyline hydrochloride for a
number of years.
The patient had had two severe depressive
episodes, neither necessitating admission to a psy-
chiatric hospital. She had a history of depressive
symptoms with irritability during the premenstrual
phase.
The patient had two sisters, one of whom was
her twin. Her sisters were married and had chil-
dren. There was no family history of psychiatric
treatment. She had been attracted to sports tradi-
tionally associated with boys until 12 years of age,
when her menstruation began.
In April 1984 the patient began to experience
irritability, became aggressive, overtalkative and
paranoid, and was full of energy. These symptoms
came to a climax in the days before and during
menstruation. With the onset of menstrual flow
her hypomanic symptoms continued to progress. A
week later she showed psychomotor hyperactivity,
insomnia, poor appetite, pressure of speech and
flight of ideas. No specific stressful life event was
found to have provoked this episode. She ex-
pressed grandiose delusions and also reported
auditory and visual hallucinations. She was taken
to the emergency department and treated with
neuroleptics (haloperidol, 20 mg/d).
The patient's mental condition stabilized with-
in 2 months with psychopharmacologic treatment,
and she returned to her job. There had been no
further relapse of mental illness after 1 year of
follow-up.
Case 2
A 29-year-old married woman had been treat-
ed as an outpatient for depression. She had a
history of depression and elation that appeared to
be seasonal: she would become depressed during
the winter and excited during the summer. There
was no clinical history of postpartum depression or
mania. However, she had a history of premenstru-
al dysphoric mood. One of her brothers had been
treated for "paranoid psychosis".
In May 1984 the patient began to experience
hallucinations. She also exhibited psychomotor
excitement, overtalkativeness, excessive elation
and euphoric mood. All of these hypomanic symp-
toms appeared in the days before her menstrua-
tion. She was admitted to a psychiatric hospital,
where she continued to exhibit manic excitement
associated with auditory and visual hallucinations,
which were congruent with her mood. Her insight
and judgement were poor, and she showed no
gross delusional ideation. She had never before
experienced manic elation but had had frequent
episodes of depression, associated at times with
suicidal ideas. Bipolar disorder was diagnosed.
The patient responded to haloperidol therapy
and was discharged a month later.
Case 3
A 31-year-old single, unemployed woman had
a 5-year history of multiple psychiatric hospitaliza-
tions and had been treated for major affective
disorders. Most of her episodes were characterized
by hypomanic symptoms associated with paranoid
ideas, irritability and insomnia. Depressive phases
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were associated with psychomotor retardation, hy-
persomnia and paranoid delusions. Most of the
relapses appeared to be seasonal, occurring around
Christmas. The patient's mother had been treated
for major depression for years. Her father was
quite anxious and insecure.
Evaluation of the patient revealed that each
relapse, whether of depression or mania, coincided
with the premenstrual phase. However, the course
of her affective disturbances did not improve with
the onset and cessation of menstrual flow, and she
required active psychiatric treatment. Between ep-
isodes she showed a dysphoric mood that began in
the premenstrual phase and was inconsistent. Sim-
ilarly, her affective disorder episodes were precipi-
tated during the premenstrual phase and became
progressively pronounced with the approach of
menstruation.
Discussion
There are a number of problems with the
research published thus far on PMS and its relation
with affective disorder (manic-depressive illness).
Most of the studies contained methodologic flaws,
which influenced the results. Moreover, several
factors limited the accuracy of the findings: failure
to agree on a standard definition of PMS, lack of
standard instruments for evaluation, inadequate
specification of the severity of symptoms, absence
of a control group in most studies, reliance on
conflicting assumptions and, consequently, con-
flicting conclusions, and diversity of diagnostic
criteria and assessment methods. For example, the
rate of diagnosis of affective disorder at some time
in the lives of women with premenstrual mood
disorder has been reported to range from 11% to
100%, depending on the investigators and their
methods and diagnostic criteria.23 Some authors
believe that studies in which prospective methods
are used to determine the prevalence of concur-
rence of PMS and affective disorders are more
reliable than those with retrospective methods.23
These and other factors have some bearing on
conflicting reports on patients with PMS.
In spite of extensive research, the cause of
PMS remains an enigma. Conflicting theories have
been presented by investigators with a biologic
versus a psychologic orientation. While the former
believe that hormonal and other biochemial imbal-
ances are the main contributing factors, the latter
consider psychologic variables to be of similar
importance.49 Yet another group with special inter-
est in the social dimension of PMS maintains that
the environmental and social climate of a woman's
life can influence her mood before menstruation.20
Negative social attitudes toward menstruation are
believed to have affected her interactions with
others. Clare,50 in his review of the literature, noted
the multifactorial aspect of the cause of PMS and
stated that "this condition may be the final stage of
multiple and interacting social, psychological and
biological factors". However, biologic factors, ma-
nifested in persistent recurrence of a cyclic pattern
of premenstrual symptoms,. are generally viewed
as being the most important.
One of the implications of a possible genetic
relation between affective disorders and PMS is
that successful treatment and control of the former
will have a similar effect on the latter. However, in
our experience examination of such a hypothesis
has resulted in conflicting conclusions. While in
some patients treatment of affective disorder allevi-
ated premenstrual mood changes, in other cases
the results have been disappointing. Lithium car-
bonate has been used in the treatment of PMS, but
the result has been unequivocal and controversial.
This suggests that the presence of heterogeneity in
affective disorder entails a greater predisposition to
manic-depression and greater responsiveness to its
treatment. However, the possible existence of a
link between these two disorders does not neces-
sarily mean that they will respond to the same
treatment, given the complex biochemical and
hormonal changes that occur in the disorders. In
our patients, although the manic-depressive ep-
isodes occurred during the premenstrual phase, the
start of the menstrual flow did not cause clinically
significant improvement in their mental state,
which suggests that other factors were involved.
Our experience confirms that women with a
personal or family history of psychiatric illnesses
such as major affective disorders are more likely to
be predisposed to PMS than women without such
a history.5" Genetic predisposition in this subgroup
of women may make them more susceptible to
clinically significant mood changes before or dur-
ing menstruation and after childbirth.
Our findings support the results of Dejong
and collaborators,23 who stated that "premenstrual
mood changes might serve as sensitizing stimuli
that, in those genetically predisposed, influence
the development, expression, or course of subse-
quent major affective episodes. Conversely, early
affective episodes may determine the characterist-
ics of a menstrually related mood disorder." Some
authors believe that a woman's age and cycle
characteristics can serve as predictors of the type
and severity of premenstrual symptoms that she
will experience."3 In women with a history of
affective disorders there may be an increase in
reported premenstrual symptoms."3 We recom-
mend that the mood swings and premenstrual
changes in women with a predisposition to affec-
tive disorders be carefully evaluated over time and
the role of psychologic, biologic and social factors
be explored. Future research should address in
particular the hypothesis of genetic predisposition
of patients with PMS to affective disorders. The
susceptibility of subtypes of patients with PMS to
affective disorders should be further explored. The
role of genetic predisposition after such women
cease to menstruate should also be examined to
determine whether they will still be susceptible to
affective disorders.
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